Job Description

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease.

We believe the Greater Boston area is an important hub for the biotech and pharma industry, which is why we’ve invested in growing our footprint and expanding our R&D space in Cambridge, with a primary focus on additional state-of-the-art lab space. Here, we will bring together talent and expertise, building upon GSK’s long history of vaccine development, to create globally leading viral capabilities and cutting-edge vaccines technologies, as we add to our robust portfolio targeting infectious diseases at every stage of life.

In the plan to create a new hub for vaccine discovery in Cambridge, we are building new laboratories that will be focused on the development of state-of-the-art methods that will be supporting deep product understanding, process and product development, as well as testing of pre-clinical and clinical samples for new vaccines.

This is a Scientist position in the Serology and Assay Development team in Viral Vaccines.  You will help develop and execute serological assays to be used for the evaluation of vaccine candidates and therapeutics.  You will bring significant knowledge of immunology and infectious diseases, and experience in executing immunoassays, which provide critical information to enable strategic decision making by the project teams.

We are looking for a highly motivated, innovative scientist with experience in multiple immunoassay formats (MSD, Luminex, ELISA, etc.) who is willing to go the extra mile to contribute to multiple projects and help develop vaccine candidates and therapeutics through preclinical development.

Key Responsibilities:

• Help develop, validate and execute immunoassays to assess antibody responses
• Work on both singleplex and multiplex immunoassay formats
• Formulate and execute assay characterization, including assessment of interference
• Analyse and interpret experimental data and document results in electronic notebooks in a detailed and concise manner
• Write detailed protocols, procedures and work instructions to support immunology assays.
• Write specific technical sections of internal and external reports
• Reporting of results in team meetings and cross-function and cross-department meetings
• Work in a highly organized manner and be able to keep track of key project-related deadlines
• Help with lab management tasks including the ordering of materials, participation in operational meetings, routine equipment maintenance
• Contribute to the maintenance of a clean and safe workplace

Basic Qualifications:

• Degree in Immunology, Virology, Microbiology, Pharmaceutical Sciences, or related scientific field.
• PhD with 0+ years of postdoctoral or industry experience, MS with 4+ years of lab experience, or BS with 8+ years of lab experience. 
• 2+ years of experience with Luminex or MSD, preferably working on multiplex formats

Preferred Qualifications:

• Prior experience with the implementation of robotic systems to increase analytical efficiencies.
• Prior experience with the analysis of human biological samples (HBS) and knowledge of the HBS specific precautions.
• Multiple years of experience in developing analytical templates in SoftMax Pro, Prism and other analytical software.
• Prior experience in statistical analysis.
• Experience in qualification and/or validation of assays for regulatory filings.
• Strong track-record of scientific publications in peer-reviewed journals or other demonstrations of scientific success.

#Vx-Cam

#Li-GSK

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?
Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.